I am a board-certified ophthalmologist with specialty training in Ophthalmic Oncology. I understand the impact that cancer can have on patients and their families, and I am dedicated to treating patients with cancer in, on, and around the eye. My goal is to give the best treatment to each patient, while limiting the adverse consequences. At Memorial Sloan Kettering we have the advantage of working closely with a team of specialized doctors (radiation oncologists, medical oncologists, pathologists, neurologists, pediatricians, etc) to generate a coordinated plan of care for our patients.
I graduated Magna Cum Laude, Phi Beta Kappa with honors from Columbia University. As part of my education, I was granted a Research Fellowship Award and spent a year at Oxford University. During my training at New York University School of Medicine I developed my interest in Ophthalmology.
After a transitional year internship at Memorial Sloan Kettering Cancer Center, I completed my ophthalmology residency at the New York Eye and Ear Infirmary, where I was elected co-chief resident and was awarded the William J. & Judith Turner Outstanding Resident Award. I then returned to Memorial Sloan Kettering to complete my specialty training and fellowship in Ophthalmic Oncology.
As a clinician-scientist, I have published numerous peer-reviewed papers. My areas of research interest include retinoblastoma and other intraocular tumors including uveal melanoma. I have written a number of textbook chapters on the subject of side effects related to cancer treatment and uveal melanoma of the eye. I have delivered lectures on my work at both national and international meetings, in places such as India, Argentina, England, France and Japan. I received an Atlantic Coast Retina Club award and am a member of the International Society for Ocular Oncology, the American Academy of Ocular Oncology and Pathology and the American Academy of Ophthalmology. I am a manuscript reviewer for sub-specialty journals including Ophthalmology, JAMA Ophthalmology, British Journal of Ophthalmology and Retina. I am the principal investigator for a National Cancer Institute (of the NIH) funded study.
- Clinical Expertise: Ophthalmic Oncology
- Languages Spoken: English
- Education: MD, New York University School of Medicine
- Residencies: Ophthalmology - New York Eye and Ear Infirmary
- Fellowships: Ophthalmic Oncology - Memorial Sloan Kettering Cancer Center
- Board Certifications: Ophthalmology
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more